000 | 01156 a2200325 4500 | ||
---|---|---|---|
005 | 20250514235303.0 | ||
264 | 0 | _c20060131 | |
008 | 200601s 0 0 eng d | ||
022 | _a0342-4642 | ||
024 | 7 |
_a10.1007/s00134-005-2740-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatejovic, Martin | |
245 | 0 | 0 |
_aNoradrenaline and the kidney: foe, friend, or both? _h[electronic resource] |
260 |
_bIntensive care medicine _cNov 2005 |
||
300 |
_a1476-8 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aNorepinephrine _xadministration & dosage |
650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
650 | 0 | 4 |
_aSympathomimetics _xadverse effects |
700 | 1 | _aTräger, Karl | |
700 | 1 | _aDe Backer, Daniel | |
773 | 0 |
_tIntensive care medicine _gvol. 31 _gno. 11 _gp. 1476-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00134-005-2740-z _zAvailable from publisher's website |
999 |
_c15726624 _d15726624 |